AstraZeneca completes acquisition of TeneoTwo EP News Bureau Aug 15, 2022 AstraZeneca has acquired all outstanding equity of TeneoTwo in exchange for an upfront payment of $100 million
AstraZeneca to acquire TeneoTwo EP News Bureau Jul 6, 2022 NB-486 will be evaluated in multiple types of lymphoma
